Adding supplemental external beam radiotherapy (EBRT) did not improve outcomes in higher-risk cancer patients who had brachytherapy, according to the long-term results of two trials. Specifically, ...
A pooled analysis of five prospective trials showed that stereotactic body radiotherapy (SBRT) was associated with a lower risk for biochemical failure over 10 years vs high-dose rate brachytherapy ...
The 15-year OS rate was 60% among prostate brachytherapy recipients and 55% among EBRT recipients, indicating no significant difference between the arms. In prostate cancer, prostate brachytherapy (PB ...
Hormone therapy use and duration with post-operative radiotherapy for recurrent prostate cancer: An individual patient data meta-analysis. This is an ASCO Meeting Abstract from the 2026 ASCO ...
Further enhancement of natural killer (NK) activities and interferon (IFN)-gamma production by recombinant human interleukin-12 (rhIL-12) in the patients with renal cell carcinoma (RCC) during the ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
G_prostate cancer_micrograph Among men receiving radiation therapy for prostate cancer, the proportion of those receiving brachytherapy dropped from 59.3% to 34.7% from 2004 to 2014, a study found.
The growing complexity of prostate cancer care has introduced a wider range of clinically accepted treatment pathways, each with distinct implications for cure rates, side effects, recovery, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results